 - Patients must have a histologically confirmed diagnosis of lymphoma expressing the CD20 antigen and generally must have failed at least one prior standard systemic therapy; the exception will be mantle cell lymphoma MCL patients, who may be enrolled while in first complete remission CR in accordance with current transplant standard of care for these patients 